Company intelligence / Profile preview

CHI Scientific

Maynard, Massachusetts, United Stateschiscientific.com ↗

Ownership: Private
Development stage: Commercial

Overview

CHI Scientific offers proprietary, standardized systems for primary cell isolation and culture, including the PrimaCell™, OptiTDS™, and FibrOut™ platforms. These systems reduce variability in cell/tissue culturing, improve reproducibility, and accelerate life science research. Their product line includes more than 300 types of primary cell culture kits as well as peptide/protein/antibody/gene services. No clinical results apply since these are laboratory tools rather than therapeutics.

Modalities: PeptidesProteinsAntibodiesGene products (e.g., gene synthesis)Cell culture reagents and kits
Industry: Drug Discovery Services

Partnerships

VWR International (distribution partner for peptide products and custom peptide services)

Beyond the preview

Go deeper on CHI Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CHI Scientific.

Explore the full profile